Tajik A, Abbasi A, Goudarzi Z, Izadi-Moud A, et al. Cost-Effectiveness and Budget Impact Analysis of Apixaban and Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation (NVAF) in Iran. Clin Cardiol 2024;47:e24311.
PMID: 38923583